Company information:
Inventa Therapeutics Limited (No: 11032260)
Address: 10 COLWICK QUAYS BUSINESS PARK ROAD NO 2, COLWICK, NOTTINGHAM, NG4 2JY, ENGLAND
Status: Active
Incorporated: 25-Oct-2017
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 11-Aug-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: ASHLEY STEPHEN CHARLES COOPER ( DOB: Oct-1960 From: Oct-2019 )
Current Director: STUART JAMES GIBSON ( DOB: Mar-1967 From: Oct-2019 )
Current Director: CHRISTOPHER NICKLIN ( DOB: Dec-1964 From: Oct-2019 )
Current Director: CHRIS NICKLIN ( DOB: Dec-1964 From: Oct-2019 )
Current Director: SHAILENDRA RAMBARAN SINGH ( DOB: Apr-1974 From: Oct-2017 )
Current Director: SHAILENDRA RAMBARAN SINGH ( From: Oct-2017 )
Persons of Significant Control:
Dr Shailendra Rambaran Singh, 4 Fairview Court West Bridgford, Nottingham, NG2 7TP, United Kingdom: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2017-10-25)
Company Accounts Summary (£)
Item | 2018 | 2020 | 2021 | 2022 | 2023 | Chart |
---|---|---|---|---|---|---|
Current assets / Debtors | 100 | 25,252 | 100.0,25252.0,0.0,0.0,0 | |||
Equity / share capital and reserves | 100 | 100.0,0.0,0.0,0.0,0 |